Trump Launches TrumpRx.gov, Offering Steep Discounts on Dozens of Popular Prescription Drugs
- Rex Ballard
- 1 day ago
- 2 min read
In a significant move aimed at tackling high prescription drug costs, President Donald Trump has launched TrumpRx.gov, a federal government-backed website that provides Americans with access to dramatically reduced prices on dozens of commonly prescribed medications. The initiative, which builds on the administration's Most-Favored-Nation pricing approach, promises savings by aligning U.S. prices closer to lower international rates, with no insurance required for eligibility.
The platform currently highlights steep cuts on high-demand drugs, particularly GLP-1 medications used for diabetes and weight loss. Key examples include:
Ozempic (semaglutide injection): Reduced to $199 per month (from an original list price of around $1,028).
Wegovy (semaglutide): Available as a pill at $149 per month or pen at $199 per month (from $1,349).
Zepbound (tirzepatide): Priced at $299 per month (from $1,087).
The site reportedly covers 43 popular drugs in total, with additional medications to be added on a rolling basis. Users can search or browse options, compare prices, and obtain coupons or direct access codes redeemable at participating pharmacies or through manufacturers. The program targets uninsured and underinsured Americans, potentially saving patients billions annually in out-of-pocket costs by bypassing traditional insurance markups.
President Trump announced the launch amid a group of pharmaceutical executives and health officials, emphasizing the program's goal of delivering "the world's lowest prices" on essential medications. The White House describes it as a major step forward in lowering drug costs for millions.
Entrepreneur Mark Cuban, founder of Cost Plus Drugs and a vocal advocate for drug price reform, has praised the initiative. In recent comments, Cuban called it "stupendous" and "the most incredible program ever," pledging cooperation to expand affordability efforts.
Critics, however, have pushed back. Senator Elizabeth Warren (D-Mass.) dismissed TrumpRx.gov as "nothing more than Donald Trump's latest vanity project," arguing that true health care affordability requires broader reforms rather than cash-pay discounts. Trump awaits Senator Warrens proposal.
Experts note that while the discounts—ranging from 33% to over 90% off list prices—can be substantial, actual savings depend on individual circumstances, such as insurance status and pharmacy participation. The site directs users to manufacturer portals or local pharmacies for fulfillment.
For more details or to check eligibility and current offerings, visit the official site at https://trumprx.gov. Additional information is available from the White House fact sheet here.
The launch marks a bold experiment in direct government intervention in drug pricing, with potential implications for future health policy debates. As more drugs are added, TrumpRx.gov could reshape how Americans access essential medications.
Sources:
